ACG Share Price

Open 0.03 Change Price %
High 0.03 1 Day 0.00 0.00
Low 0.03 1 Week 0.00 0.00
Close 0.03 1 Month 0.00 0.00
Volume 91957 1 Year -0.06 -66.67
52 Week High 0.10
52 Week Low 0.02
ACG Important Levels
Resistance 2 0.03
Resistance 1 0.03
Pivot 0.03
Support 1 0.03
Support 2 0.03
ASX Australia Most Active Stocks
DUE 3.02 1.00%
DUE 3.02 1.00%
NWE 0.01 0.00%
NWE 0.01 0.00%
NWE 0.01 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
LKO 0.00 0.00%
BLY 0.03 -25.00%
ASX Australia Top Gainers Stocks
KSO 0.40 3900.00%
ADX 0.02 100.00%
ADX 0.02 100.00%
ADX 0.02 100.00%
HHM 0.02 100.00%
AOK 0.02 100.00%
BNV 0.03 50.00%
PMQ 0.03 50.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
ASX Australia Top Losers Stocks
RRS 0.00 -100.00%
RRS 0.00 -100.00%
RRS 0.00 -100.00%
RRP 0.08 -90.59%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
TCQ 0.27 -73.53%
GDY 0.01 -50.00%

AtCor Medical Holdings Ltd (ASX: ACG)

ACG Technical Analysis 5
As on 19th Sep 2017 ACG Share Price closed @ 0.03 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.06 & Strong Sell for SHORT-TERM with Stoploss of 0.04 we also expect STOCK to react on Following IMPORTANT LEVELS.
ACG Target for September
1st Target up-side 0.04
2nd Target up-side 0.05
3rd Target up-side 0.06
1st Target down-side 0.02
2nd Target down-side 0.01
3rd Target down-side N/A
ACG Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Medical Appliances & Equipment
Offical website
ACG Address
1059-1063 Victoria Road
Unit 11
West Ryde, NSW 2114
ACG Latest News
Interactive Technical Analysis Chart AtCor Medical Holdings Ltd ( ACG ASX Australia )
Java support must be enabled in order to display FnCharts.
You can download Java from
Your Comments and Response on AtCor Medical Holdings Ltd
ACG Business Profile
AtCor Medical Holdings Limited, together with its subsidiaries, designs, manufactures, and markets medical devices for use in cardiovascular management worldwide. The company offers SphygmoCor family of products that provides tools for non-invasive assessment of the cardiovascular system, which focuses on central blood pressures, measures of arterial stiffness, and autonomic function. It provides SphygmoCor XCEL, which consists of the SphygmoCor XCEL PWA device that measures central aortic blood pressure and augmentation index; and The SphygmoCor XCEL PWA and PWV device to measure a patient’s central aortic blood pressure and augmentation index, as well as the patients carotid-femoral pulse wave velocity. The company also offers SphygmoCor Cardiovascular Management System System (CVMS), a portable device used to non-invasively obtain important vital cardiovascular data that cannot be obtained with traditional brachial cuff blood pressure measurements. Its SphygmoCor CVMS product range includes SphygmoCor CP system for use in every clinical setting, including home care and military applications; the SphygmoCor CPV system for pulse wave velocity assessment in patient care, research, and pharmaceutical clinical trials; and the SphygmoCor CPVH system for the analysis of time and frequency domains, and measures sympathetic and parasympathetic activity. In addition, the company provides SphygmoCor Continuous Monitoring (CM) system for continuous and real time, beat-to-beat central pressure waveform data and other cardiovascular parameters. It operates primarily in Australia, the Americas, the Middle East, Africa, Asia, and New Zealand. AtCor Medical Holdings is based in West Ryde, Australia.